Finally, the aberrant activation of the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway has gained increasing interest for its potential role in DDLPS. The gene discussed is MTOR; the disease is dedifferentiated liposarcoma.